Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy.
Nancy A DreyerStella C F BlackburnShahrul Mt-IsaJonathan Luke RichardsonSimon Hugh Lynton ThomasMaja LaursenPriscilla Zetstra-van der WoudeAnna Jamry-DziurlaValerie HlivaAlison BourkeLolkje de Jong-van den BergPublished in: JMIR public health and surveillance (2015)
Self-reported information on medication use as well as other potential teratogenic factors can be collected via the Internet, although recruitment costs are not insubstantial and maintaining follow-up is challenging. Direct data collection from consumers adds detail, but clinical input may be needed to fully understand patients' medical histories and capture birth outcomes.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- healthcare
- peritoneal dialysis
- electronic health record
- type diabetes
- emergency department
- patient reported outcomes
- skeletal muscle
- metabolic syndrome
- human health
- climate change
- insulin resistance
- gestational age
- pregnant women
- drug induced
- data analysis